Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CB-839 and Capecitabine in Advanced Solid Tumors and PIK3CA Mutant Colorectal Cancer
NCT02861300Phase 2Completed
- Start
- Sep 2016
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of telaglenastat in colorectal cancer (CRC), solid tumor. Started Sep 2016; status: completed.
02
Drugs
telaglenastat
03
Conditions
colorectal cancer (CRC)solid tumor
Beyond the preview
Go deeper on NCT02861300.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02861300.